We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis

By LabMedica International staff writers
Posted on 16 Jun 2020
Image: The evaporation of sweat on paper pads could be used for fluid transport in a wearable device over long periods of time. The resulting dry layer of caked salts would preserve a `time-stamped` record of biomarkers of interest (Photo courtesy of Dr. Orlin D. Velev and co-authors, North Carolina State University)
Image: The evaporation of sweat on paper pads could be used for fluid transport in a wearable device over long periods of time. The resulting dry layer of caked salts would preserve a `time-stamped` record of biomarkers of interest (Photo courtesy of Dr. Orlin D. Velev and co-authors, North Carolina State University)
By cleverly manipulating paper geometry, researchers created a paper-based wearable device to collect, transport, and analyze sweat for an extended period.

Sweat can be used to obtain an exact measurement of concentrations of medications in the blood. Furthermore, the concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids such as sweat predict the physical and mental state of the individual.

A major problem that has so far restricted the use of wearable paper-based sweat sensors is that sweat contains salt, which, upon evaporation, becomes deposited on the device and interferes with fluid flow. To solve this problem, investigators at North Carolina State University (Raleigh, USA) characterized and analyzed how capillary action and evaporation could cooperatively be used to transport and process a sweat-like fluid containing dissolved salts and model analytes.

The investigators postulated that the joint action of capillary wicking and evaporation would sustain continuous and long-term withdrawal of the sweat-like fluid. In the laboratory they then demonstrated that paper strips of controlled geometry could passively pump fluid for sensing purposes for long duration. Thus, non-invasive osmotic extraction combined with paper microfluidics and evaporative disposal enabled sweat collection and monitoring for periods exceeding 10 days. Since the process was driven by the liquid wicking through paper, the device did not require an external power source.

The investigators also demonstrated that the salt film deposited at the evaporation pad would eventually lead to cessation of the process but at the same time would preserve a record of analytes that could be used for long-term biomarker monitoring in sweat.

"We expected that the flow of the model sweat will be suppressed by the deposition of a salt layer inside the drying pad," said senior author Dr. Orlin Velev, professor of chemical and biomolecular engineering at North Carolina State University. "By following the flow of model sweat, we found, quite surprisingly, that such a simple paper construct can achieve continuous sweat pumping and disposal for very long periods."

The wearable device for sweat analysis was described in the June 9, 2020, online edition of the journal Biomicrofluidics.

Related Links:
North Carolina State University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
All-in-One Molecular System
AIO M160
Thyroid Test
Anti-Thyroid EIA Test

Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more